澳洲央行行长指不可能采用负利率, 美国生物科技公司所研发的疫苗效用率高达 94.5%

In 每日市场分析
November 17, 2020

澳洲央行行长指不可能采用负利率
澳洲央行行长洛威於出席一场网络研讨会上表示,近期数据好於预期,病毒限制措施缓亦提振信心,若衞生领域有更多好消息,将可能实现更快速的反弹,又指未来的挑战更可能是创造就业。此外,他又认为目前不是加息的时候,并强调极不可能采用负利率,只有在全球主要国家采用负利率的情况下才会考虑。

美国生物科技公司所研发的疫苗效用率高达94.5%
美国生物科技公司公布的最新新冠疫苗测试数据,其一款研发的疫苗在第三期研究结果中效用率更高达94.5%,比先前美国大型药厂所公布的效用率约 90%更高。且值得注意是,该款疫苗不须於超低温储存,只需正常的冷藏即可,保存期可长达 30 日,较此前预计的 7 日更长。而在低温急冻情况下,其存放时间也将更长。近期有关新冠疫苗的好消息不断,持续带动市场投资气氛。

————————————
Z. com Bullion为日本上市集团GMO Financial Holdings, Inc 旗下关联公司。杠杆式保证金交易存在高风险 , 有关风险请浏览公司网站https://bullion.z.com/tc/about/legal/risk/

場外式黃金/白銀交易的風險:
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.